CN104004063B - 一种关于Npas2蛋白激动剂多肽及其应用 - Google Patents
一种关于Npas2蛋白激动剂多肽及其应用 Download PDFInfo
- Publication number
- CN104004063B CN104004063B CN201410289014.XA CN201410289014A CN104004063B CN 104004063 B CN104004063 B CN 104004063B CN 201410289014 A CN201410289014 A CN 201410289014A CN 104004063 B CN104004063 B CN 104004063B
- Authority
- CN
- China
- Prior art keywords
- polypeptide
- npas2
- protein agonist
- npas2 protein
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410289014.XA CN104004063B (zh) | 2014-06-25 | 2014-06-25 | 一种关于Npas2蛋白激动剂多肽及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410289014.XA CN104004063B (zh) | 2014-06-25 | 2014-06-25 | 一种关于Npas2蛋白激动剂多肽及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104004063A CN104004063A (zh) | 2014-08-27 |
CN104004063B true CN104004063B (zh) | 2016-08-24 |
Family
ID=51364991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410289014.XA Active CN104004063B (zh) | 2014-06-25 | 2014-06-25 | 一种关于Npas2蛋白激动剂多肽及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104004063B (zh) |
-
2014
- 2014-06-25 CN CN201410289014.XA patent/CN104004063B/zh active Active
Non-Patent Citations (3)
Title |
---|
EAX01830.1;Genbank;《Genbank》;20140514;第1-2页 * |
The Circadian Gene NPAS2, a Putative Tumor Suppressor, Is Involved in DNA Damage Response;Aaron E. Hoffman等;《Mol Cancer Res》;20080930;第6卷(第9期);1461-1468 * |
生物钟基因Npas2在老年乳腺癌患者中的表达及其临床意义;李新白等;《中国老年学杂志》;20120531;第32卷(第9期);全文 * |
Also Published As
Publication number | Publication date |
---|---|
CN104004063A (zh) | 2014-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cai et al. | Effect of Withaferin A on A549 cellular proliferation and apoptosis in non-small cell lung cancer | |
CN105056250B (zh) | 一种microRNA在制备治疗前列腺癌的药物中的应用 | |
CN104004063B (zh) | 一种关于Npas2蛋白激动剂多肽及其应用 | |
CN104004056B (zh) | 一种关于Cyclin D蛋白抑制剂多肽及其应用 | |
CN110946948A (zh) | 化风丹在制备抗乳腺癌药物中的应用 | |
CN104706649A (zh) | 千层纸素苷在制备抗肿瘤药中的应用 | |
CN116650474A (zh) | 苍耳亭的医药新用途 | |
CN104045691B (zh) | Npas2蛋白激动剂多肽及其应用 | |
CN104017051B (zh) | 一种Cyclin D 蛋白抑制剂多肽及其应用 | |
CN104055786B (zh) | 苜蓿酸-3-O-β-D-吡喃葡萄糖苷、苜蓿酸及其盐在制备防治肿瘤药物中的应用 | |
CN104017052B (zh) | 关于Npas2蛋白激动剂多肽及其应用 | |
CN104045692B (zh) | 一种Npas2蛋白激动剂多肽及其应用 | |
CN104045689B (zh) | 一种关于生长抑素受体激动剂多肽及其应用 | |
CN107693509A (zh) | Sb‑fi‑26在制备治疗乳腺癌药物中的应用 | |
CN104004062B (zh) | 关于per2蛋白激动剂多肽及其应用 | |
CN104031128B (zh) | 一种白介素-33抑制剂多肽及其应用 | |
CN104045690B (zh) | 生长抑素受体激动剂多肽及其应用 | |
CN104045693B (zh) | 一种关于per2蛋白激动剂多肽及其应用 | |
CN104017053B (zh) | 一种per2蛋白激动剂多肽及其应用 | |
CN104004059B (zh) | 一种关于白介素-33抑制剂多肽及其应用 | |
CN104004060B (zh) | Cyclin D蛋白抑制剂多肽及其应用 | |
CN104086630B (zh) | 一种生长抑素受体激动剂多肽及其应用 | |
CN103602625B (zh) | 含有重组腺病毒质粒的大肠杆菌及重组腺病毒的应用 | |
CN103127057A (zh) | 梣酮在制备抗肿瘤药物中的应用 | |
CN104694521A (zh) | 水解纤维蛋白溶酶原多肽及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Maoyu Inventor before: Luo Ruixue |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160630 Address after: 266300 Jiaozhou Central Hospital, Xuzhou Road, Qingdao, Shandong, No. 29,, China Applicant after: Wang Maoyu Address before: High tech Zone Suzhou city Jiangsu province 215000 Chuk Yuen Road No. 209 Applicant before: Suzhou Pu Luo Da Biotechnology Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190203 Address after: 510610 Unit A1007-09, Block A, 161 Linhe West Road, Tianhe District, Guangzhou City, Guangdong Province Patentee after: Guangzhou Haiyachuan Electronic Commerce Co., Ltd. Address before: 266300 Jiaozhou Road Central Hospital, No. 29 Xuzhou Road, Jiaozhou, Qingdao, Shandong, China Patentee before: Wang Maoyu |
|
TR01 | Transfer of patent right |